120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Detrusor Underactivity
Choi Sae-Woong, ÃÖ¿ë¼±, ¹è¿õÁø, ±è¼öÁø, Á¶ÇõÁø, È«¼ºÈÄ, ÀÌÁö¿, ȲÅ°ï, ±è¼¼¿õ,
¼Ò¼Ó »ó¼¼Á¤º¸
( Choi Sae-Woong )
Seoul St.Mary¡¯s Hospital Department of Urology
ÃÖ¿ë¼± ( Choi Yong-Sun )
Seoul St.Mary¡¯s Hospital Department of Urology
¹è¿õÁø ( Bae Woong-Jin )
Seoul St.Mary¡¯s Hospital Department of Urology
±è¼öÁø ( Kim Su-Jin )
Seoul St.Mary¡¯s Hospital Department of Urology
Á¶ÇõÁø ( Cho Hyuk-Jin )
Seoul St.Mary¡¯s Hospital Department of Urology
È«¼ºÈÄ ( Hong Sung-Hoo )
Seoul St.Mary¡¯s Hospital Department of Urology
ÀÌÁö¿ ( Lee Ji-Youl )
Seoul St.Mary¡¯s Hospital Department of Urology
ȲÅ°ï ( Hwang Tae-Kon )
Seoul St.Mary¡¯s Hospital Department of Urology
±è¼¼¿õ ( Kim Sae-Woong )
Seoul St.Mary¡¯s Hospital Department of Urology
KMID : 0358320110520120824
Abstract
Purpose: Most men with benign prostatic hyperplasia (BPH) have bothersome lower urinary tract symptoms (LUTS). This study aimed to investigate the safety and efficacy of high-performance system (HPS) laser photoselective vaporization of the prostate (PVP) for the treatment of BPH in men with detrusor underactivity (DU).
Materials and Methods: From March 2009, 371 patients with BPH were divided into 2 groups according to the findings of preoperative urodynamic study: 239 (64.4%) patients with bladder outlet obstruction (BOO) and 132 (35.6%) patients with bladder outlet obstruction with detrusor underactivity (BOO+DU). 120 W HPS laser PVP was performed to resolve the BOO. The perioperative data and postoperative results at 1 month and 12 months, including the International Prostate Symptom Score (IPSS), maximum urinary flow (Qmax), and postvoid residual urine (PVR) values, were evaluated.
Results: Compared with the preoperative parameters, significant improvements in IPSS, Qmax, and PVR were observed in each group at 1 and 12 months after the operation. In addition, IPSS, Qmax, and PVR were not significantly different between the BOO and BOO+DU groups at 1 and 12 months after the operation.
Conclusions: Surgery to relieve BOO in the patients with BPH seems to be an appropriate treatment modality regardless of the existence of DU.
Å°¿öµå
Bladder dysfunction; Laser therapy; Prostatic hyperplasia
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸